Catalysts
(Diabetes) Oral Insulin: Data from new tablet prototype
(Anticoagulants) Solid Oral UF Heparin: Data from multiple dosing study; Comparable activity to PROTECT liquid dosage form
(Obesity) Oral PYY3-36: Initiate first-into-man safety studies (FIMSS)
(Various) Feasibility candidates: Progress programs into partnerships